The weight you lost during your Ozempic treatment may come back after you stop using the drug
Our commitment is to transparency, ethical communication, and patient educationensuring that anyone exploring peptides understands both their potential and their limitations
Verdiperstat (MPO inhibitor) has been clinically tested in Phase 1 and Phase 2 trials on approximately 250 healthy volunteers and patients
We have a program in MASH, in the liver, the LIVERAGE program, plus a robust data-generation program to Eli Lilly used the American Diabetes Associations annual meeting to announce that its investigational triple agonist retatrutide can treat the conditions obesity drives, beyond the excess weight itself
This information should be clearly documented in medical records to ensure all healthcare professionals involved in the patient's care are aware
Chuang ST, Chu P, Sugimura J, Tretiakova MS, Papavero V, Wang K et al